Elgia Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Elgia Therapeutics's estimated annual revenue is currently $620k per year.
- Elgia Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Elgia Therapeutics has 4 Employees.
- Elgia Therapeutics grew their employee count by 0% last year.
Elgia Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Operating Officer | Reveal Email/Phone |
Elgia Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Elgia Therapeutics?
Elgia Therapeutics, a venture-backed biopharmaceutical company, is positioned to deliver first-in-class and best-in-class therapies for serious chronic diseases, such as fibrosis, neuroinflammation, NASH, kidney disease, and inflammatory bowel disease (IBD). The Elgia team has discovered how metabolic stress drives inflammation and fibrosis and has identified untapped protein targets for small molecule drug discovery. By combining these pioneering biological insights with R&D expertise, Elgia is creating innovative medicines for debilitating chronic diseases.
keywords:N/A
N/A
Total Funding
4
Number of Employees
$620k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.3M | 4 | 0% | N/A |
#2 | $0.4M | 4 | N/A | N/A |
#3 | $0.3M | 4 | N/A | N/A |
#4 | $0.3M | 4 | N/A | N/A |
#5 | $0.3M | 4 | N/A | N/A |